Clinical Trials in Pittsburgh

Showing 9581-9600 of 21,047 trials

A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders

NCT03833128

The purpose of this Phase 1b study is to assess REN001 safety in subjects with fatty acid oxidation disorders.

Reneo Pharma Ltd24 participantsStarted Apr 2019

Aurora, Colorado, United States • Portland, Oregon, United States • Pittsburgh, Pennsylvania, United States +4 more locations

TERMINATEDPhase 1< 1 mile

RTX-321 Monotherapy in Patients With HPV 16+ Tumors

NCT04672980

This is an open-label, multicenter, multiple-ascending dose, FIH, Phase 1 study of RTX-321 for the treatment of patients that are HLA-A\*02:01 positive with persistent, recurrent, or metastatic, unresectable, HPV 16+ cancers.

Cervical CancerHead and Neck CancerAnal Cancer

Rubius Therapeutics9 participantsStarted Apr 2021

Birmingham, Alabama, United States • Los Angeles, California, United States • Aurora, Colorado, United States +7 more locations

A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders

RTX-321 Monotherapy in Patients With HPV 16+ Tumors

Find Trials by Condition in Pittsburgh

Heart Rate Variability and Stress Management Enhancement

Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials (BMT CTN 1205)

Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban

eXciteOSA for Treatment of Mild Obstructive Sleep Apnea

Weight Loss for Prediabetes Using Episodic Future Thinking

The International Diabetes Closed Loop (iDCL) Trial: Protocol 1

Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain

Detection of Heart Conditions With Single Lead ECG Using Artificial Intelligence

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma

S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata

Negative Pressure Wound Therapy to Reduce Surgical Site Infection

DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory